McKinsey to pay $78M US opioid settlement with health insurers, company benefit plans
Published
Consulting giant McKinsey & Company agreed to a $78 million settlement in a case over its role in advising opioid manufacturers to design misleading marketing campaigns. A group of U.S. health insurers and company benefit plans, referred to in court documents as third-party payors, alleged in the…
#mckinseycompany #charlesrbreyer #mckinsey #kevinsneader #bobsternfels #fda #sternfels